Condition
EUS Guided Biopsy
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Not Yet Recruiting2
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07240818Not ApplicableNot Yet Recruiting
Comparison of FNB to EUS-CNB for Pancreatic Lesions
NCT07424456Not Yet RecruitingPrimary
Comparison Between Triphasic CT Abdomen and EUS-FNB in Characterization of Pancreatic Lesion
NCT07168863Recruiting
EUS-guided FNB-induced PANCREatitis Assessment
NCT03672032Not ApplicableCompletedPrimary
SharkCore Versus Acquire FNB
Showing all 4 trials